VinoMetro: phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy
ONCOLOGY RESEARCH AND TREATMENT. Bd. 40. 2017 S. 88-88
Erscheinungsjahr: 2017
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Krajnak, S. (Autor)
Decker, T. (Autor)
Fehm, T. (Autor)
Fuxius, S. (Autor)
Harbeck, N. (Autor)
Juhasz-Boess, I. (Autor)
Moebus, V. (Autor)
Thomssen, C. (Autor)
Seehase, M. (Autor)
Schollenberger, L. (Autor)
Ruckes, C. (Autor)
Schmidt, M. (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
